Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial. (Q42490396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

author name string

M De Lena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

V Lorusso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

M Brandi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

P Calabrese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

S Romito

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

A Mazzei

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

F Marzullo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

Medical oncology and tumor pharmacotherapy

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

163-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

The management of generalised grade 2 non-Hodgkin's lymphomas (Report no 18)

29 September 2019

cites work

1 reference

12 December 2020

Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas

1 reference

12 December 2020

Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma

1 reference

12 December 2020

Epirubicin in non-Hodgkin's lymphomas

1 reference

12 December 2020

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

12 December 2020

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

1 reference

12 December 2020

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

12 December 2020

Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histi

1 reference

12 December 2020

Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma

1 reference

12 December 2020

High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study

1 reference

12 December 2020

Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases

1 reference

12 December 2020

The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.

1 reference

12 December 2020

Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma

1 reference

12 December 2020

Toxic and therapeutic activity of 4'-epi-doxorubicin

1 reference

12 December 2020

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

12 December 2020

A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02985240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2473364%20AND%20SRC:MED&resulttype=core&format=json

release_q6tgzu2fe5aazlze6kk2jbdism

29 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q6tgzu2fe5aazlze6kk2jbdism

24 November 2022

mapped directly with Wikidata item

1 reference